PSMA PET/CT versus MRI for mapping prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two imaging techniques—PSMA PET/CT and MRI—to see which one better finds and outlines prostate cancer tumors. You'll receive both scans to help doctors understand which method works best for newly diagnosed prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newly diagnosed prostate cancer confirmed by biopsy
- Medium-to-high risk prostate cancer (intermediate, high, or very high risk)
- Age 18 or older
- Good overall health (able to carry out light activities)
- Expected to live at least 5 more years
- Recent PSMA PET/CT scan (within 3 months) and MRI biopsy results (within 6 months)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special PET scan (PSMA-PET) plus MRI is better than MRI alone at finding the full extent of high-risk prostate cancer before surgery. It aims to improve surgical planning by checking scan results against the removed prostate tissue.
This study tests whether a special scan (PSMA PET/MRI) combined with a standard MRI can better detect prostate cancer. It is for men who have not had a biopsy yet and are suspected of having prostate cancer.
This study tests whether a special PET scan (PSMA PET) can better detect prostate cancer in men whose MRI results are unclear. If it works, it may help avoid unnecessary biopsies or find cancer sooner.
This trial tests if combining a PSMA PET scan with an MRI can better detect clinically significant prostate cancer than MRI alone. It may help men who have not had a prostate biopsy before and have certain risk factors.
This study tests whether using a special PET scan (PSMA PET/CT) to guide prostate biopsy can help find cancer more accurately and in real time. It might help men who need a biopsy because of high PSA levels or abnormal MRI results.
This study uses a special scan called PET/MR with a prostate-focused tracer to help doctors choose the best next treatment for prostate cancer. It may be most helpful if you are planning major treatment or if your cancer has come back after prior treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.